Effective with date of service Nov. 15, 2022, Medicaid and NC Health Choice cover Eflapegrastim-xnst injection, for subcutaneous use (Rolvedon).
When the service location field is not completed, the Alt EVV vendor will receive an exception notice.
This bulletin replaces the previous bulletin published Nov. 21, 2022.
Please provide feedback by Jan. 6, 2023
Replaces the prior version issued in February 2022
A multidisciplinary care team will provide whole-person care management that addresses all of a beneficiary’s needs
Upcoming milestones, Provider Playbook updates, organizational Provider affiliation requirement, Beneficiary assignment file and more
Effective Dec. 1, 2022, pharmacy providers who administer immunizations at pharmacies may bill NC Medicaid Direct for vaccines on pharmacy claims
This bulletin provides guidance to assist hospital providers’ compliance with federal requirements.
Effective with date of service Oct. 3, 2022, Medicaid and NC Health Choice cover Ranibizumab-eqrn injection, (Cimerli)